Let Element's discovery chemistry team keep your pipeline full and your drug discovery programs advancing toward the clinic. You'll cut costs and expedite time to market with ÌÇÐÄlogoÃ×·ÆÍÃas your CRO and CDMO partner.

Get answers to key questions in the discovery process from hit exploration/expansion, hit-to-lead, and lead optimization. No matter what stage you’re in, we deliver compounds to move your program forward. You can count on ÌÇÐÄlogoÃ×·ÆÍÃfor robust QC - we deliver bioassay data you can trust while our compound management team moves compounds from chemistry to testing. We're committed to delivering you the high quality data you need quickly.

Discovery phase programs can be further accelerated when in vitro assays are run through Element's discovery biology team. Compounds move seamlessly to the assay biologists for study. And, as your program matures, our process development team can help you develop a plan for moving to IND and clinical trials.

Wherever your program is in the discovery/development process, get there faster with ÌÇÐÄlogoÃ×·ÆÍÃas part of your team. Ready to start the conversation? Let's talk.

The ÌÇÐÄlogoÃ×·ÆÍÃadvantage

Seamlessly spin up and wind down projects through an FTE (full-time equivalent) arrangement with Element. Extend your chemistry capacity with ÌÇÐÄlogoÃ×·ÆÍÃscientists or build an entire med chem project team group without investing in chemistry infrastructure. 

Discovery efforts are tailored to meet your needs - ranging from collaborative efforts to full exploratory medicinal chemistry endeavors. Interested in knowing more? Request more information

Custom synthesis

  • Rapid delivery mg to kg scale
  • Solid phase synthesis
  • Synthesis of new analogs
  • Hit to lead
  • SAR expansion
  • Lead optimization
  • Multi-step custom synthesis of complex targets
  • Reference compounds
  • Metabolites
  • Substrates
  • Stable isotope labeled compounds

Discovery chemistry specialization

  • Focused libraries platform
  • Fragment based drug discovery
  • Expertise in pro-drug approaches, conjugates, PEG
  • Controlled substances R&D (Schedule II - V)
  • Controlled substances analytical and bulk manufacturing licenses (Schedule II-V)

Our team of over 9,000 Engaged Experts in North America, Europe, The Middle East, Australia, Asia and Africa are ready to help you.